Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|June 24, 2022
Sustained delivery approaches to improving adaptive immune responsesBen S Ou, Olivia M Saouaf, Julie Baillet, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
A regimen compression strategy for commercial vaccines leveraging an injectable hydrogel depot technology for sustained vaccine exposureJerry Yan, Ben S Ou, Olivia M Saouaf, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 13, 2026
Sustained Delivery of a Shingles Subunit Vaccine Overcomes Age-Related Declines in Humoral and Cellular Immunity Relative to ShingrixYe Eun Song, Jerry Yan, Ben S Ou, et al.
Advanced Healthcare Materials|February 16, 2025
Highly Extensible Physically Crosslinked Hydrogels for High-Speed 3D BioprintingYe Eun Song, Noah Eckman, Samya Sen, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Sustained Delivery of a Shingles Subunit Vaccine Overcomes Age-Related Declines in Humoral and Cellular Immunity Relative to ShingrixYe Eun Song, Jerry Yan, Ben S Ou, et al.
Scientific Reports|February 15, 2020
Quantifying residue-specific conformational dynamics of a highly reactive 29-mer peptideWilliam R Lindemann, Ethan D Evans, Alexander J Mijalis, et al.
ACS Biomaterials Science & Engineering|January 6, 2021
Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer-Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza VaccinationGillie A Roth, Olivia M Saouaf, Anton A A Smith, et al.
Advanced Healthcare Materials|June 6, 2023
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS-CoV-2 Subunit VaccineBen S Ou, Olivia M Saouaf, Jerry Yan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza VaccinesOlivia M Saouaf, Ben S Ou, Ye Eun Song, et al.
ACS Nano|January 12, 2024
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesBen S Ou, Julie Baillet, Vittoria C T M Picece, et al.
Pageof 2